.png){kind=icon}
返回
The Fat Kidney
.png){kind=icon}
OA
AI
DOI：10.1007/s13679-023-00500-9.png)
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Purpose of ReviewThe purpose of this review is to summarize the current evidence on the role of obesity in the development and progression of chronic kidney disease and the current evidence on nutritional, pharmacological, and surgical strategies for the management of individuals with obesity and chronic kidney disease.Recent FindingsObesity can hurt the kidney via direct pathways, through the production of pro-inflammatory adipocytokines, and indirectly due to systemic complications of obesity, including type 2 diabetes mellitus and hypertension. In particular, obesity can damage the kidney through alterations in renal hemodynamics resulting in glomerular hyperfiltration, proteinuria and, finally, impairment in glomerular filtratation rate. Several strategies are available for weight loss and maintenance, such as the modification of lifestyle (diet and physical activity), anti-obesity drugs, and surgery therapy, but there are no clinical practice guidelines to manage subjects with obesity and chronic kidney disease.Obesity is an independent risk factor for the progression of chronic kidney disease. In subjects with obesity, weight loss can slow down the progression of renal failure with a significant reduction in proteinuria and improvement in glomerular filtratation rate. Specifically, in the management of subjects with obesity and chronic renal disease, it has been shown that bariatric surgery can prevent the decline in renal function, while further clinical studies are needed to evaluate the efficacy and safety on the kidney of weight reducing agents and the very low-calorie ketogenic diet.
Keyword:
Chronic kidney disease
Obesity
Hyperfiltration
Diet
Tirzepatide
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
11
论文数:
585
被引数:
4.2K
机构
引用论文
Comparison of Mechanical Properties of Thin Copper Films Processed by Electrodeposition and RollingOAAI
OAAI分享收藏European Guidelines for Obesity Management in Adults with a Very Low-Calorie Ketogenic Diet: A Systematic Review and Meta-Analysis欧洲极低热量生酮饮食成人肥胖管理指南: 系统评价和荟萃分析.png)
OBESITY FACTSOAAI
OBESITY FACTSIF4.7
OAAI分享收藏Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial杜拉鲁肽与2型糖尿病的心血管结局 (REWIND): 一项双盲，随机安慰剂对照试验LANCET
LANCETIF88.5
PREAI
分享收藏
查看更多内容